EN 13975-2003 en Sampling procedures used for acceptance testing of in vitro diagnostic medical devices - Statistical aspects《体外诊断用医疗装置的验收试验用取样规程 统计特性》.pdf

《EN 13975-2003 en Sampling procedures used for acceptance testing of in vitro diagnostic medical devices - Statistical aspects《体外诊断用医疗装置的验收试验用取样规程 统计特性》.pdf》由会员分享，可在线阅读，更多相关《EN 13975-2003 en Sampling procedures used for acceptance testing of in vitro diagnostic medical devices - Statistical aspects《体外诊断用医疗装置的验收试验用取样规程 统计特性》.pdf（16页珍藏版）》请在麦多课文档分享上搜索。

1、BRITISH STANDARD BS EN 13975:2003 Sampling procedures used for acceptance testing of in vitro diagnostic medical devices Statistical aspects The European Standard EN 13975:2003 has the status of a British Standard ICS 11.100 BS EN 13975:2003 This British Standard was published under the authority of

2、 the Standards Policy and Strategy Committee on 28 March 2003 BSI 28 March 2003 ISBN 0 580 41510 4 National foreword This British Standard is the official English language version of EN 13975:2003. The UK participation in its preparation was entrusted to Technical Committee CH/212, IVDs, which has t

3、he responsibility to: A list of organizations represented on this committee can be obtained on request to its secretary. Cross-references The British Standards which implement international or European publications referred to in this document may be found in the BSI Catalogue under the section enti

4、tled “International Standards Correspondence Index”, or by using the “Search” facility of the BSI Electronic Catalogue or of British Standards Online. This publication does not purport to include all the necessary provisions of a contract. Users are responsible for its correct application. Complianc

5、e with a British Standard does not of itself confer immunity from legal obligations. aid enquirers to understand the text; present to the responsible international/European committee any enquiries on the interpretation, or proposals for change, and keep the UK interests informed; monitor related int

6、ernational and European developments and promulgate them in the UK. Summary of pages This document comprises a front cover, an inside front cover, the EN title page, pages 2 to 12, an inside back cover and a back cover. The BSI copyright date displayed in this document indicates when the document wa

7、s last issued. Amendments issued since publication Amd. No. Date CommentsEUROPEANSTANDARD NORMEEUROPENNE EUROPISCHENORM EN13975 March2003 ICS11.100 Englishversion Samplingproceduresusedforacceptancetestingofinvitro diagnosticmedicaldevicesStatisticalaspects Procduresdchantillonnageutilisespourlaccep

8、tation desessaisdesdispositifsmdicauxdediagnosticinvitro Aspectsstatistiques ProbenahmeverfahrenfrdieAnnahmeprfungvonInvitro DiagnostikaStatistischeAspekte ThisEuropeanStandardwasapprovedbyCENon14November2002. CENmembersareboundtocomplywiththeCEN/CENELECInternalRegulationswhichstipulatetheconditions

9、forgivingthisEurope an Standardthestatusofanationalstandardwithoutanyalteration.Uptodatelistsandbibliographicalreferencesconcernings uchnational standardsmaybeobtainedonapplicationtotheManagementCentreortoanyCENmember. ThisEuropeanStandardexistsinthreeofficialversions(English,French,German).Aversion

10、inanyotherlanguagemadebytra nslation undertheresponsibilityofaCENmemberintoitsownlanguageandnotifiedtotheManagementCentrehasthesamestatusasthe official versions. CENmembersarethenationalstandardsbodiesofAustria,Belgium,CzechRepublic,Denmark,Finland,France,Germany,Greece, Hungary,Iceland,Ireland,Ital

11、y,Luxembourg,Malta,Netherlands,Norway,Portugal,Slovakia,Spain,Sweden,SwitzerlandandUn ited Kingdom. EUROPEANCOMMITTEEFORSTANDARDIZATION COMITEUROPENDENORMALISATION EUROPISCHESKOMITEEFRNORMUNG ManagementCentre:ruedeStassart,36B1050Brussels 2003CEN Allrightsofexploitationinanyformandbyanymeansreserved

12、 worldwideforCENnationalMembers. Ref.No.EN13975:2003EEN13975:2003(E) 2 Foreword Thisdocument(EN13975:2003)hasbeenpreparedbyTechnicalCommitteeCEN/TC140,“Invitrodiagnostic medicaldevices“thesecretariatofwhichisheldbyDIN. ThisEuropeanStandardshallbegiventhestatusofanationalstandard,eitherbypublicationo

13、fanidenticaltextor byendorsement,atthelatestbySeptember2003,andconflictingnationalstandardsshallbewithdrawnatthe latestbySeptember2003. ThisdocumenthasbeenpreparedunderamandategiventoCENbytheEuropeanCommissionandtheEuropean FreeTradeAssociation,andsupportsrequirementsofEUDirective(s). Forrelationshi

14、pwithEUDirective(s),seeinformativeannexZA,whichisanintegralpartofthisdocument. AnnexAisinformative. AccordingtotheCEN/CENELECInternalRegulations,thenationalstandardsorganizationsofthefollowing countriesareboundtoimplementthisEuropeanStandard:Austria,Belgium,CzechRepublic,Denmark,Finland, France,Germ

15、any,Greece,Hungary,Iceland,Ireland,Italy,Luxembourg,Malta,Netherlands,Norway,Portugal, Slovakia,Spain,Sweden,SwitzerlandandtheUnitedKingdom.EN13975:2003(E) 3 Introduction ThisEuropeanStandardrelatestoAnnexVI“ECVERIFICATION“oftheDirective98/79/ECoftheEuropean ParliamentandoftheCouncilof27October1998o

16、ninvitrodiagnosticmedicaldevices,settingoutrequirements forsamplingproceduresusedforacceptancetestingofinvitrodiagnosticmedicaldevicesbyanotifiedbody. InAnnexVIthreeprovisionsforverificationaredescribed: Section5providesforverificationbyexaminationandtestingofeveryfinisheddevice; Section6.3providesf

17、orverificationbasedonstatisticalcontrolbyattributesand/orvariables; Section2.2providesforalternativeconformityassessmentproceduresforthosesituationswherestatistical verificationasspecifiedinSection6.3isconsideredtobenotappropriate. Thefirstprovisionisnotconsideredinthepresentstandardsincetheassociat

18、edsamplingplanrequiresno statisticalconsiderations. Thesecondprovisionisappliedwhensufficientcertaintyontheresultofsuchverificationonfinisheddevicescan begainedbyasamplingplanestablishedonastatisticalbasis.Forthispurposeexistingstandardsonacceptance testingcanbeapplied. Thethirdprovisionisaddressedi

19、nSection2.2ofAnnexVIwhichstatesthat: “TotheextentthatforcertainaspectsthefinaltestingaccordingtoSection6.3isnotappropriate,adequate inprocesstesting,monitoringandcontrolmethodsshallbeestablishedbythemanufacturerwiththeapprovalof thenotifiedbody.TheprovisionofAnnexIV,Section5,shallapplyaccordinglyinr

20、elationtotheabovementioned approvedprocedures.“ AnnexIV,Section5,prescribessurveillanceandapprovalofamanufacturersqualitysystem. Itiscurrentstateoftheartthatinspectionandverificationofthefinisheddevicesiscomplementarytoprocess controlandfinaltestingperformedbythemanufacturer.Performanceverificationi

21、sgenerallyperformedby measurementsondefinedcontrolmaterialsoradefinedpanelofreferencespecimens(e.g.sera). Validconclusionscanonlybedrawnfromalimitednumberofunitsofthefinalproduct,ifadequateinprocess testing,monitoringandcontrolproceduresensurethehomogeneityofthefinalproductbatchanditscomponentsat th

22、eintermediatestage(s)ofmanufactureaswellasthesuitabilityoftheprocessapplied.Anysamplingplanused forfinaltestingofinvitrodiagnosticmedicaldevicesisbasedonstatisticalconsiderations.Thisdoesnot necessarilymeanthatalargenumberofunitsissampledandtested.Inmanycasesusingverysmallsamplesizes (sometimesequal

23、tooneunit)canbeanacceptableapproach,providedthatanadequatelevelofconformityhas beendemonstratedbyotherappropriatemeans. Followingthislastapproach,thisstandardcanalsobeusedforestablishingsamplingprocedureswhenannexIIIor IVorVIIisapplied.EN13975:2003(E) 4 1Scope ThisEuropeanStandardspecifiessamplingpr

24、ocedurerequirementsforacceptancetestingoffinishedinvitro diagnosticmedicaldevices,whichrequireECverificationbyanotifiedbody. Twodifferentprovisionsareaddressed: a) verificationbytestingattributesand/orvariablesonastatisticalbasis; b) verificationbytestingahomogeneousbatchwhichhasbeendefinedbyappropr

25、iatemeansofprocess validationandinprocesscontrol. Thisstandardspecifiesrequirementsandcriteriafortestingprocedurestoestablishandverifythehomogeneityof processesandproducts.Thisstandardisalsoapplicablefordrawingupsamplingplansforfinishedproducts accordingtotherequirementslaiddownformanufacturersprodu

26、ctcertificationandproductionqualitysystems. 2 Normativereferences ThisEuropeanStandardincorporatesbydatedorundatedreferenceprovisionsfromotherpublications.These normativereferencesarecitedattheappropriateplacesinthetextandthepublicationsarelistedhereafter.For datedreferences,subsequentamendmentsto,o

27、rrevisionsof,anyofthesepublicationsapplytothisEuropean Standardonlywhenincorporatedinitbyamendmentorrevision.Forundatedreferencesthelatesteditionofthe publicationreferredtoapplies(includingamendments). ISO28591, Samplingproceduresforinspectionbyattributes Part1:Samplingplansindexedbyacceptable quali

28、tylevel(AQL)forlotbylotinspection. ISO28592, Samplingproceduresforinspectionbyattributes Part2:Samplingplansindexedbylimitingquality (LQ)forisolatedlotinspection. ISO28593, Samplingproceduresforinspectionbyattributes Part3:Skiplotsamplingprocedures. ISO3951, Samplingproceduresandchartsforinspectionb

29、yvariablesforpercentnonconforming. 3 Termsanddefinitions ForthepurposesofthisEuropeanStandard,thefollowingtermsanddefinitionsapply. 3.1 acceptablequalitylevel AQL qualitylevelthatforthepurposeofsamplinginspectionofacontinuousseriesofbatchesisthelimitofa satisfactoryprocessaverage 3.2 acceptancetesti

30、ng samplinginspection processofinspectingasampleoftheunitsofproductthatmakeupabatchforthepurposeofacceptingor rejectingtheentirebatch,asprescribedintheassociatedpreestablishedsamplingplanEN13975:2003(E) 5 3.3 batch lot definedamountofmaterial,eitherstartingmaterial,intermediateorfinishedproductwhich

31、isuniforminits propertiesandhasbeenproducedinoneprocessorseriesofprocesses EN375:2001 3.4 batchacceptance procedureofestablishingconformityofabatchwiththedevicespecifications 3.5 invitrodiagnosticmedicaldevice IVDMD anymedicaldevicewhichisareagent,reagentproduct,calibrator,controlmaterial,kit,instru

32、ment,apparatus, equipmentorsystem,whetherusedaloneorincombination,intendedbythemanufacturertobeusedinvitrofor theexaminationofspecimens,includingbloodandtissuedonations,derivedfromthehumanbody,solelyor principallyforthepurposeofprovidinginformationconcerningaphysiologicalorpathologicalstate,orconcer

33、ning congenitalabnormality,ortodeterminethesafetyandcompatibilitywithpotentialrecipients,ortomonitor therapeuticmeasures Directive98/79/EC NOTE1 Aspecimenreceptacle,whethervacuumtypeornot,isconsideredtobeaninvitrodiagnosticmedicaldevicewhen itisspecificallyintendedbyitsmanufacturerfortheprimaryconta

34、inmentandpreservationofspecimensderivedfromthehuma n bodyforthepurposeofinvitrodiagnosticexamination. NOTE2 Productsforgenerallaboratoryusearenotinvitrodiagnosticmedicaldevicesunlesssuchproducts,inviewoftheir properties,arespecificallyintendedbytheirmanufacturertobeusedforinvitrodiagnosticexaminatio

35、n. 3.6 inspectionbyattributes inspectionmethodwherebytheunitofproductisclassifiedsimplyasconformingornonconformingwithrespectto agivenrequirementorsetofrequirements 3.7 inspectionbyvariables inspectionmethodwherebyaspecifiedquantitativepropertyismeasuredinasampleofunitsofproduct,either componentsorf

36、inisheddevices,toestablishstatisticallytheacceptabilityofabatch 3.8 limitingquality LQ whenabatchisconsideredinisolation,aqualitylevelwhichforthepurposesofsamplinginspectionislimitedtoa lowprobabilityofacceptance ISO28591:1999 3.9 sample oneormoreunitsofproduct,eithercomponentsorfinisheddevices,draw

37、nfromabatchwithoutregardtothe qualityoftheunits 3.10 samplesize numberofunitsofproductinthesample 3.11 samplingplan planthatindicatesthenumberofunitsofproduct,eithercomponentsorfinisheddevices,fromeachbatchwhichis tobedrawnforinspectionandtheassociatedcriteriafordeterminingtheacceptabilityofthebatch

38、EN13975:2003(E) 6 NOTE Asamplingplaneithercontainsorreferstoinstructionsforthesamplingstrategy. 3.12 samplingstrategy establishedmethodforobtaininganadequatesample EXAMPLE Randomselection,stratified,withstatedfrequency,rationalsubgrouping. 3.13 validation confirmation,throughtheprovisionofobjectivee

39、vidence,thattherequirementsforaspecificintendeduseor applicationhavebeenfulfilled ENISO9000:2000 NOTE1 Processvalidationmeansestablishingbyobjectiveevidencethataprocessconsistentlyproducesaresultor productmeetingitspredeterminedspecifications. NOTE2 Designvalidationmeansestablishingbyobjectiveeviden

40、cethatdevicespecificationsconformwithuserneedsand intendeduse(s). 3.14 verification confirmation,throughtheprovisionofobjectiveevidence,thatspecifiedrequirementshavebeenfulfilled ENISO9000:2000 4Procedures 4.1General Samplingproceduresusedforbatchacceptancetestingshallbeanintegralpartoftheoperationa

41、lqualitycontrol strategyforanyparticularinvitrodiagnosticmedicaldeviceandshalltakethenatureofthatproductandpossible consequencesofnonconformityintoaccount,i.e.ensureahighlevelofsafetyandperformanceaccordingtothe stateoftheart. Batchacceptanceshallbebasedon,either: verificationbyexaminationandtesting

42、ofeveryunitofproduct(finisheddevices); statisticalverificationofabatchoffinisheddevices; processcontrol,complemented,whereappropriate,byfinaltestingoffinisheddevices; anappropriatecombinationofsuchqualitycontrolmeasures. NOTE Thesamplingprocedureforverificationandtestingofeveryunitofproductrequiresn

43、ostatisticalconsiderationsand isthereforenotelaboratedinthisstandard. Samplingproceduresforbatchacceptance,asapartoftheoperationalqualitycontrolstrategy,shallbeproperly validated. Validationshalldemonstrateamongstothersthat: thesuitabilityofstartingandmanufacturingmaterialsisdefinedbyrelevantcharacteristics; thevariationofingredientsintermsofe.g.amount,concentrationoractivitylieswithinspecifiedtolerance limitsasshownbyappropriatecontrolofprocesses;EN13975:2003(E) 7 producthomogeneitywithinspecifiedlimitsisensured; themanuf